Article · 18 Dec 2025
Short communicationPublished 2015
DHCR24: A Novel HCC Biomarker at a Glance
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The sustained increase of hepatocellular carcinoma (HCC) new cases and the failure of determining a “universal” biomarker for early detection are sounding the alarm about finding urgently new alternatives and develop new biomarkers in order to face this public health issue. Hereby, a highlight of new findings about the involvement of 3β-hydroxysterol Δ24-reductase (DHCR24) as a potential biomarker of hepatitis C disease progression to hepatocellular carcinoma and a valuable target for hepatitis C virus (HCV) related HCC therapy.
Subjects
MicrobiologyInfectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Microbiology: Open Access.
Article · 18 Dec 2025
Culture-Based and Molecular Assessment of Microbial Diversity
Article · 18 Dec 2025
Antimicrobial Resistance Detection and Microbial Identification
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Microbiology: Open Access
- SubjectMicrobiology
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Khadija Rebbani”
- BylineArticles whose byline prints “Kyoko Tsukiyama-Kohara”